Screening all pregnant women admitted to labor and delivery for the virus responsible for coronavirus disease 2019
GHDx Entry last modified on: Jan 31, 2024
Data by Data Type
Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 infection in the craft and manual worker population of Qatar
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of SARS-CoV-2 antibodies in South Korea
GHDx Entry last modified on: Dec 19, 2023
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 infection in Africa: A systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021. Preprint
GHDx Entry last modified on: Dec 20, 2023
SARS-CoV-2 Infection During Pregnancy and Associated Perinatal Health Outcomes: A National US Cohort Study
GHDx Entry last modified on: Apr 10, 2023
Seroepidemiological study on the spread of SARS-CoV-2 in populations in especially affected areas in Germany - Study protocol of the CORONA-MONITORING lokal study
GHDx Entry last modified on: Dec 12, 2023
Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months
GHDx Entry last modified on: Mar 22, 2024
Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Socioeconomic status and well-being during COVID-19: A resource-based examination
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Random Sample of Inhabitants of the Katowice Region, Poland
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 Prevalence among Outpatients during Community Transmission, Zambia, July 2020
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 infection in a municipality in southern Brazil
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital
GHDx Entry last modified on: Mar 14, 2022
Slow Spread of SARS-CoV-2 in Southern Brazil Over a 6-Month Period: Report on 8 Sequential Statewide Serological Surveys Including 35611 Participants
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 infection in pregnancy in Denmark-characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population-based cohort study
GHDx Entry last modified on: Apr 10, 2023
Symptom cluster analysis of long COVID-19 in patients discharged from the Temporary COVID-19 Hospital in Mexico City
GHDx Entry last modified on: Mar 22, 2024
Seroprevalence of Hepatitis A and Hepatitis E Viruses among Pregnant Women in Northern Iran
GHDx Entry last modified on: Nov 22, 2024
Seroprevalence and epidemiological characteristics of immunoglobulin M and G antibodies against SARS-CoV-2 in asymptomatic people in Wuhan, China: a cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Severe and fatal forms of COVID-19 in children
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020
GHDx Entry last modified on: Jan 31, 2024
Searching for COVID-19 Antibodies in Czech Children-A Needle in the Haystack
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2: big seroprevalence data from Pakistan-is herd immunity at hand?
GHDx Entry last modified on: May 12, 2022
Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in Mazandaran province, Iran
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of COVID-19 in Palestine in 2020. Preprint
Epi surveillance
SARS-CoV-2 Infections in Households in a Peri-Urban Community of Lima, Peru: A Prospective Cohort Study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020 [version 1; peer review: 1 approved with reservations
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 Infection among Pregnant and Postpartum Women, Kenya, 2020-2021
GHDx Entry last modified on: Apr 10, 2023
Smoking Attributable Risk in Multiple Sclerosis
GHDx Entry last modified on: Apr 10, 2023
SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study
GHDx Entry last modified on: Feb 16, 2023
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
GHDx Entry last modified on: Mar 14, 2022
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
GHDx Entry last modified on: Jan 31, 2024
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of SARS-CoV-2 in migrant workers in Kuwait
GHDx Entry last modified on: Mar 14, 2022
Six-Month Outcomes in Patients Hospitalized with Severe COVID-19
GHDx Entry last modified on: Jan 31, 2024
Staff SARS-CoV-2 Seroprevalence and Mental Health as Key Factors in University Response to COVID-19 Pandemic
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence, prevalence, and genomic surveillance: monitoring the initial phases of the SARS-CoV-2 pandemic in Betim, Brazil. Preprint
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 infection in pregnant women and newborns in two maternity hospitals in Salvador-Bahia, Brazil
GHDx Entry last modified on: Jan 31, 2024
Substantial increase in stillbirth rate during the COVID-19 pandemic: results from a population-based study in the Indian state of Bihar
GHDx Entry last modified on: Mar 22, 2024
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors. Preprint
GHDx Entry last modified on: May 12, 2022
Pages
Subscribe
